Healthcare Services

Necrotizing Enterocolitis Market Growth Expected to Reach $6.94 Billion by 2030 with 6.1% CAGR

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Necrotizing Enterocolitis Market From 2026 To 2030?

The market for necrotizing enterocolitis has demonstrated robust expansion over recent years. Projections indicate its value will increase from $5.14 billion in 2025 to $5.47 billion by 2026, achieving a compound annual growth rate (CAGR) of 6.4%. Factors contributing to its historical growth include the frequent occurrence of premature births, inadequate neonatal care facilities, the prevalent use of broad-spectrum antibiotics, challenges in timely diagnosis within resource-constrained environments, and the early adoption of parenteral nutrition.

The necrotizing enterocolitis market is anticipated to show significant expansion in the upcoming years, projected to reach $6.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This expansion over the forecast period is attributable to increasing investments in neonatal intensive care units, advancements in regenerative and stem cell therapies, heightened awareness of early nec detection, a rise in the adoption of precision nutrition therapies, and the growth of neonatal imaging innovations. Noteworthy trends during this period include the increased embrace of probiotics and prebiotics for nec prevention, a greater emphasis on early diagnosis and screening in premature infants, expanding utilization of individualized TPN solutions, the spread of minimally invasive surgical interventions, and ongoing improvements in neonatal critical care and monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22068&type=smp

What Drivers Are Influencing The Necrotizing Enterocolitis Market?

The rising incidence of premature births is projected to stimulate the growth of the necrotizing enterocolitis market in the coming years. Premature births, also known as preterm births, are defined as the delivery of an infant before 37 weeks of gestation, contrasting with the typical 40-week pregnancy duration. The increase in premature births can be attributed to maternal health conditions such as high blood pressure, diabetes, and infections, which elevate the likelihood of preterm labor, as well as lifestyle factors including smoking, drug use, and poor nutrition, contributing to a greater chance of early deliveries. A higher number of premature births leads to more cases of necrotizing enterocolitis (NEC) because premature infants possess immature gastrointestinal systems, making them more susceptible to inflammation and infection. For instance, in January 2024, data from the Centers for Disease Control and Prevention, a US-based government agency, indicated that premature births constitute 8.67% of total births annually in the United States. Therefore, the growing number of premature births is propelling the expansion of the necrotizing enterocolitis market.

Which Segments Are Included In The Analysis Of The Necrotizing Enterocolitis Market?

The necrotizing enterocolitis market covered in this report is segmented –

1) By Treatment: Total Parenteral Nutrition (TPN), Gastrointestinal Decompression, Antimicrobial Therapy, Antifungal Treatment, Paracentesis, Other Treatments

2) By Diagnosis: Laboratory Tests, Imaging Techniques

3) By Stage: Stage I (Suspected Necrotizing Enterocolitis), Stage II (Definite Necrotizing Enterocolitis), Stage III (Advanced Necrotizing Enterocolitis)

4) By End-User: Hospitals, Neonatal Intensive Care Units (NICUs), Specialty Clinics

Subsegments:

1) By Total Parenteral Nutrition (TPN): Standard TPN Formulations, Customized Or Individualized TPN Solutions, Lipid Emulsions For TPN, Protein And Amino Acid Supplements In TPN, Micronutrient And Electrolyte-Enhanced TPN

2) By Gastrointestinal Decompression: Nasogastric Tube (NG Tube) Decompression, Orogastric Tube Decompression, Surgical Gastrostomy For Decompression, Non-Surgical Decompression Techniques

3) By Antimicrobial Therapy: Broad-Spectrum Antibiotics, Gram-Positive Coverage Antibiotics, Gram-Negative Coverage Antibiotics, Combination Antibiotic Therapy, Prophylactic Antibiotic Strategies For High-Risk Neonates

4) By Antifungal Treatment: Systemic Antifungal Therapy, Prophylactic Antifungal Therapy For Preterm Infants, Combination Antifungal And Antibiotic Therapy For Severe NEC

5) By Paracentesis: Diagnostic Paracentesis, Therapeutic Paracentesis, Guided Paracentesis using Ultrasound Or Radiological Techniques

6) By Other Treatments: Probiotics And Prebiotics for NEC Prevention, Surgical Interventions, Stem Cell Therapy And Regenerative Medicine Approaches, Immunomodulatory Therapies, Supportive Care

What Trends Are Affecting The Expansion Of The Necrotizing Enterocolitis Market?

Leading companies within the necrotizing enterocolitis market are concentrating on developing innovative product solutions, such as cell-free sterile biologic solutions, to meet the critical unmet need for effective treatments and improve outcomes for premature infants. A cell-free sterile biologic solution is defined as a purified, sterile liquid comprising bioactive molecules like proteins, growth factors, and cytokines, derived from cultured cells but without any intact cells, designed to foster healing and mitigate inflammation. For instance, in December 2023, Noveome Biotherapeutics, Inc., a US-based biopharmaceutical company, received notification from the U.S. Food and Drug Administration (FDA), authorizing it to proceed with its Phase 1-2 clinical trial for ST266, a novel biologic targeting the treatment of necrotizing enterocolitis (NEC) in premature infants. This marks a significant milestone, as ST266 is projected to be the first major therapeutic advancement for NEC in over 30 years, addressing a crucial medical necessity given the disease’s elevated morbidity and mortality rates among vulnerable populations.

Which Key Industry Participants Are Active In The Necrotizing Enterocolitis Market?

Major companies operating in the necrotizing enterocolitis market are Abbott Laboratories, Astellas Pharma Inc., Mayo Foundation for Medical Education and Research, Cleveland Clinic, Boston Children’s Hospital, Hollister Incorporated, UPMC Children’s Hospital of Pittsburgh, Prolacta Bioscience Inc., Evolve BioSystems, Sigma-Tau Pharmaceuticals, Mead Johnson & Company LLC, Liminal BioSciences Inc., Noveome Biotherapeutics Inc., Infant Bacterial Therapeutics, Prometic Life Sciences Inc., Nexilico, Siolta Therapeutics, ProThera Biologics Inc., Plakous Therapeutics Inc., Chosen Diagnostics Inc.

Read the full necrotizing enterocolitis market report here:

https://www.thebusinessresearchcompany.com/report/necrotizing-enterocolitis-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Necrotizing Enterocolitis Market?

North America was the largest region in the necrotizing enterocolitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the necrotizing enterocolitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Necrotizing Enterocolitis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22068&type=smp

Browse Through More Reports Similar to the Global Necrotizing Enterocolitis Market 2026, By The Business Research Company

Lipid Global Market Report

https://www.thebusinessresearchcompany.com/report/lipid-global-market-report

Antidiabetics Global Market Report

https://www.thebusinessresearchcompany.com/report/antidiabetics-global-market-report

Lip Care Product Global Market Report

https://www.thebusinessresearchcompany.com/report/lip-care-product-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795